Back
Akebia Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
AKBA
Sponsored
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
36
AKBA
Akebia Therapeutics
Last Price:
1.37
Seasonality Move:
-5.8%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Akebia Therapeutics Price Quote
$1.37
+0.01 (+0.74%)
(Updated: September 19, 2024 at 6:55 PM ET)
Akebia Therapeutics Key Stats
Sell
36
Akebia Therapeutics (AKBA)
is a Sell
Day range:
$1.35 - $1.41
52-week range:
$0.78 - $2.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.54
P/B ratio:
0%
Volume:
1.3M
Avg. volume:
1.7M
1-year change:
9.68%
Market cap:
$286M
Revenue:
$194.6M
EPS:
$-0.21
How Much Does Akebia Therapeutics Make?
-
How Much Are Akebia Therapeutics's Sales Annually?
AKBA Revenues are $194.6M -
How Much Profit Does Akebia Therapeutics's Make A Year?
AKBA net income is -$51.9M
Is Akebia Therapeutics Growing As A Company?
-
What Is Akebia Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.23% -
What Is Akebia Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Akebia Therapeutics Stock Price Performance
-
Did Akebia Therapeutics Stock Go Up Last Month?
Akebia Therapeutics share price went down by -5.56% last month -
Did AKBA's Share Price Rise Over The Last Year?
AKBA share price rose by 9.68% over the past 1 year
What Is Akebia Therapeutics 52-Week High & Low?
-
What Is Akebia Therapeutics’s 52-Week High Share Price?
Akebia Therapeutics has traded as high as $2.48 over the past 52 weeks -
What Is Akebia Therapeutics’s 52-Week Low Share Price?
Akebia Therapeutics has traded as low as $0.78 over the past 52 weeks
Akebia Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Akebia Therapeutics?
-
How Much Debt Does Akebia Therapeutics Have?
Total long term debt quarterly is $38M -
How Much Cash Does Akebia Therapeutics Have?
Cash and short term investments quarterly total is $39.5M -
What Is Akebia Therapeutics’s Book Value Per Share?
Book value per share is -0.16
Is Akebia Therapeutics Cash Flow Positive?
-
What Is AKBA Cash Flow From Operations?
Cash flow from operations (TTM) is -$39M -
What Is Akebia Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $24.9M -
What Is Akebia Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$29K
Akebia Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
AKBA return on invested capital is -671.06% -
What Is Akebia Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -17.19% -
What Is AKBA Return On Equity?
ROE is a measure of profitability and is 0%
Akebia Therapeutics Earnings Date & Stock Price
-
What Is Akebia Therapeutics's Stock Price Today?
A single share of AKBA can be purchased today for 1.36 -
What Is Akebia Therapeutics’s Stock Symbol?
Akebia Therapeutics trades on the nasdaq under the ticker symbol: AKBA -
When Is Akebia Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Akebia Therapeutics is scheduled on November 8, 2024 -
When Is AKBA's next ex-dividend date?
Akebia Therapeutics's next ex-dividend date is September 20, 2024 -
How To Buy Akebia Therapeutics Stock?
You can buy Akebia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Akebia Therapeutics Competitors
-
Who Are Akebia Therapeutics's Competitors?
Below is a list of companies who compete with Akebia Therapeutics or are related in some way:
Akebia Therapeutics Dividend Yield
-
What Is AKBA Dividend Yield?
Akebia Therapeutics’s dividend yield currently is 0% -
What Is Akebia Therapeutics’s Payout Ratio?
Akebia Therapeutics’s payout ratio is 0% -
When Did Akebia Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Akebia Therapeutics’s Dividend Per Share?
Akebia Therapeutics pays a dividend of $0.00 per share
Akebia Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 20% |
Revenue: | -22.58% | -0.01% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 5.50 |
Upside from Last Price: | 304.41% |